About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease in which the immune system attacks healthy cells, typically around the joints, causing swelling and deformity. Generally ...

A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. Results from a Phase 2b clinical trial, published today in The Lancet by researchers led ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...

A number of injectable medications have been approved to provide some relief from rheumatoid arthritis. But researchers believe that one of them may actually prevent the disease from progressing, if ...

A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk. A drug used to treat rheumatoid arthritis could also prevent the disease in individuals ...

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of heart disease in people ...

Popular medications for weight loss and diabetes control could have a surprising bonus benefit, according to some anecdotal reports. Some people with rheumatoid arthritis who use GLP-1 drugs — such as ...

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in ...